The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Bridion 100 mg/ml solution for injection

Merck Sharp & Dohme BVEU/1/08/466/1-2

Main Information

Trade NameBridion 100 mg/ml solution for injection
Active SubstancesSugammadex
Dosage FormSolution for injection
Licence HolderMerck Sharp & Dohme BV
Licence NumberEU/1/08/466/1-2

Group Information

ATC CodeV03AB Antidotes
V03AB35 sugammadex


License statusAuthorised
Licence Issued25/07/2008
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back